NFKB1 and Crohn disease: Crohn’s disease-associated NOD2 polymorphisms exhibit a reduced capacity to activate NF-κβ following muramyl dipeptide stimulation, suggesting that the loss of NOD2 activation promotes Crohn’s disease33.